Nicholas Financial Reports 4th Quarter Results
May 17, 2017 22:13 pm UTC| Business
CLEARWATER, Fla., May 17, 2017 -- Nicholas Financial, Inc. (NASDAQ:NICK) announced that for the three months ended March 31, 2017, diluted earnings per share decreased 140.0% to a net (loss) of $(0.14) as compared to a...
Nicholas Financial Reports 4th Quarter Results
May 17, 2017 22:13 pm UTC| Business
CLEARWATER, Fla., May 17, 2017 -- Nicholas Financial, Inc. (NASDAQ:NICK) announced that for the three months ended March 31, 2017, diluted earnings per share decreased 140.0% to a net (loss) of $(0.14) as compared to a...
GCP Applied Technologies Announces Completion Of Stirling Lloyd Acquisition
May 17, 2017 21:45 pm UTC| Business
CAMBRIDGE, Mass., May 17, 2017 -- GCP Applied Technologies Inc. (NYSE:GCP) announced today that it has closed on its acquisition of UK-based Stirling Lloyd, a global supplier of high-performance liquid waterproofing and...
Finisar to Announce Fiscal Fourth Quarter and Full Year 2017 Financial Results
May 17, 2017 21:42 pm UTC| Business
SUNNYVALE, Calif., May 17, 2017 -- Finisar Corporation (NASDAQ:FNSR), a global technology leader in high-speed optical communications, will announce its fiscal fourth quarter and full year 2017 financial results for the...
May 17, 2017 21:39 pm UTC| Business
ONTARIO, Calif., May 17, 2017 -- Auto-Graphics, Inc., an Industry-leading library management software provider and the first to provide Web-based library resource management solutions to library consortia, is excited to...
First Savings Financial Group, Inc. Announces Quarterly Cash Dividend
May 17, 2017 21:30 pm UTC| Business
CLARKSVILLE, Ind., May 17, 2017 -- First Savings Financial Group, Inc. (Nasdaq:FSFG) (the “Company”), the holding company for First Savings Bank, today announced that its Board of Directors declared a quarterly cash...
Agios to Present New Clinical Data from its IDH Programs at ASCO
May 17, 2017 21:30 pm UTC| Business
– Updated Data from IDHIFA® (Enasidenib) Phase 1 Trial in IDH2m R/R AML to be Presented in Oral Presentation; Abstract Selected for Best of ASCO Program – – First Data from the Ivosidenib (AG-120) Phase 1...